Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Virginia Commonwealth University
Study ID
NCT07426913
Status
Recruiting
Apply to this trial

Conditions

  • Anthracycline Related Cardiotoxicity in Breast Cancer
  • Breast Cancer
  • Trastuzumab
  • Virtual Reality

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cardiovascular Health Education and Gaming through Virtual Reality — BEHAVIORAL
    Prior to engaging the intervention, participants will complete a baseline survey. The virtual reality intervention will be delivered at one infusion treatment. Participants will complete all education modules and affiliated games. The education focuses on potentially cardiotoxic treatments (e.g., anthracyclines), ways to identify cancer treatment related cardiovascular dysfunction, and heart healthy behaviors that survivors can initiate during survivorship. Following the intervention participants will complete a survey similar to the baseline survey. One-month following the intervention participants will complete one final survey.

Study Details

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).

Key Dates

Start date
May 20, 2026
Status verified
Jun 2026
Primary completion
Jul 30, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Virtual Reality Group
    Individuals in this arm will receive access to the virtual reality in cardiovascular health education and gaming intervention

Primary Outcome Measure

CTRCD Knowledge [ Time Frame: Baseline, within 2 days post-Intervention, and 4 weeks post-intervention ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Adult Outpatient PavilionRichmondVirginia23220
Victoria Williams
[email protected]
8048277363
Cellular Immunotherapies and Transplant DepartmentRichmondVirginia23220
Victoria Williams
[email protected]
8048277363
VCU Health at Stony PointRichmondVirginia23223
Victoria Williams
[email protected]
8048277363

Find similar trials in Richmond, VA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Adult Outpatient Pavilion· Richmond, VACellular Immunotherapies and Transplant Department· Richmond, VAVCU Health at Stony Point· Richmond, VA

Related Studies